United Therapeutics Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,116,984 916,076 743,183 592,899
Cost of Revenue 131,127 119,297 88,904 67,674
Gross Profit 985,857 796,779 654,279 525,225
Operating Expenses
Research and Development 299,348 173,387 180,015 165,306
Sales, General and Admin. 394,010 201,746 156,482 188,606
Non-Recurring Items - - - -
Other - - - -
Operating Income 292,499 421,646 317,782 171,313
Income From Continuing Operations
Add'l Income/Expense Items 4,462 35,664 2,702 3,708
Earnings Before Interest and Tax 296,961 457,310 320,484 174,861
Interest Expense 18,058 16,639 21,367 19,710
Earnings Before Tax 278,903 440,671 299,117 155,151
Income Tax 104,343 136,229 81,874 43,945
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - (160)
Net Income Cont. Operations 174,560 304,442 217,243 111,206
Non Recurring Events
Discontinued Operations - - 625 (5,290)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 174,560 304,442 217,868 105,916
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 174,560 304,442 217,868 105,916